BGI
REPL icon

B Group Inc’s Replimune Group REPL Stock Holding History

B Group Inc’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Buy
+26,000
New +$199K 0.15% 20

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

B Group Inc's REPL Position: Q1 2026 in Review

B Group Inc opened a new position in Replimune Group (REPL) in Q1 2026: 26,000 shares worth $199K. The stake represents 0.15% of the portfolio and ranks #20 among its holdings.

180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • B Group Inc held 26,000 shares of Replimune Group worth $199K as of Q1 2026.
  • Replimune Group was a new B Group Inc position in Q1 2026.
  • Replimune Group made up 0.15% of B Group Inc's portfolio in Q1 2026, its #20 holding.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.